Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference
Alamar Biosciences, a leader in Precision Proteomics, announced it will present at the BofA Securities 2026 Healthcare Conference, showcasing its NULISA technology and ARGO HT System aimed at early disease detection through biomarker analysis.